PND9 Exploring Serious Adverse Events Associated With Hospitalizations in a Long-term, Phase 3, Open-Label, Repeat-Dose, Safety Study of Diazepam Nasal Spray for Patients With Epilepsy

Authors

• Michael Sperling

Publication/Presentation Date

6-2021

Volume

24

Issue

1

First Page

159

Last Page

159

Published In/Presented At

https://doi.org/10.1016/j.jval.2021.04.793

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article